Early research (Phase 1)Study completedNCT04252339What this trial is testingRLY-1971 in Subjects With Advanced or Metastatic Solid TumorsWho this might be right forSolid Tumor, Unspecified, Adult Hoffmann-La Roche 56
Early research (Phase 1)UnknownNCT05610202What this trial is testingTolerability and Pharmacokinetics Study of TQB3702 Tablets in Hematologic Tumor SubjectsWho this might be right forHematologic Malignancy Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 137
Early research (Phase 1)Study completedNCT01225302What this trial is testingLinifanib (ABT-869) in Combination With Carboplatin/Paclitaxel in Japanese Subjects With Non-Small Cell Lung Cancer (NSCLC)Who this might be right forNon-Small Cell Lung Cancer AbbVie 12
Testing effectiveness (Phase 2)Looking for participantsNCT06799637What this trial is testingStudy of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard TreatmentsWho this might be right forAdvanced Solid TumorsPancreatic CarcinomaOvarian Cancer+1 more Evopoint Biosciences Inc. 350
Early research (Phase 1)Study completedNCT02625857What this trial is testingSafety & Immunogenicity of JNJ-64041809, a Live Attenuated Double-deleted Listeria Immunotherapy, in Participants With Metastatic Castration-resistant Prostate CancerWho this might be right forProstatic Neoplasms, Castration-Resistant Janssen Research & Development, LLC 26
Large-scale testing (Phase 3)Study completedNCT01156857What this trial is testingPGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine LeiomyomataWho this might be right forUterine Fibroids PregLem SA 209
Large-scale testing (Phase 3)Active Not RecruitingNCT03246529What this trial is testingA Phase III, Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and Granulocyte Colony Stimulating Factor (G-CSF) as Compared to Placebo and G-CSF for the Mobilization of Hematopoietic Stem Cells for Autologous Transplantation in Subjects With Multiple Myeloma (MM)Who this might be right forMultiple Myeloma BioLineRx, Ltd. 180
Large-scale testing (Phase 3)Active Not RecruitingNCT03654053What this trial is testingMulti-Center Study of the Effects of Simvastatin on Hepatic Decompensation and Death in Subjects Presenting With High-Risk Compensated CirrhosisWho this might be right forCirrhosis VA Office of Research and Development 142
Testing effectiveness (Phase 2)Study completedNCT00831545What this trial is testingStudy to Evaluate the Efficacy and Safety of Temozolomide in Subjects With Brain Metastases of Either Malignant Melanoma, Breast, or Non-small Cell Lung Cancer (P02064)Who this might be right forMetastases of Central Nervous SystemMelanomaBreast Neoplasm+1 more Merck Sharp & Dohme LLC 162
Not applicableStudy completedNCT01590472What this trial is testingDo Your Genes Put You at a Higher Risk of Developing MesotheliomaWho this might be right forMesothelioma Wake Forest University 69
Testing effectiveness (Phase 2)Looking for participantsNCT06854445What this trial is testingClinical Trial of TQB2825 Injection Combined With Chemotherapy in Subjects With Diffuse Large B-cell LymphomaWho this might be right forDiffuse Large Cell B-lymphoma Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. 55
Testing effectiveness (Phase 2)Ended earlyNCT03361228What this trial is testingEvaluate the Safety, Tolerability, and Antitumor Activity of INCB001158 Plus Epacadostat, With or Without Pembrolizumab, in Advanced Solid TumorsWho this might be right forSolid Tumors Incyte Corporation 5
Early research (Phase 1)Looking for participantsNCT06019702What this trial is testingClinical Study of Personalized mRNA Vaccine Encoding Neoantigen Alone in Subjects With Advanced Digestive System NeoplasmsWho this might be right forDigestive System Neoplasms Sir Run Run Shaw Hospital 20
Early research (Phase 1)UnknownNCT05843305What this trial is testingBPI-452080 in Subjects With Solid TumorsWho this might be right forSolid TumorRenal Cell CarcinomaVon Hippel-Lindau Disease Betta Pharmaceuticals Co., Ltd. 87
Early research (Phase 1)Looking for participantsNCT07121946What this trial is testingThis is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin LymphomaWho this might be right forNon-Hodgkin Lymphoma Refractory/ RelapsedDLBCL - Diffuse Large B Cell LymphomaMantle Cell Lymphoma (MCL)+2 more LTZ Therapeutics, Inc. 42
Not applicableStudy completedNCT05272423What this trial is testingStudying Pathways of Resistance in KRAS-driven CancersWho this might be right forKRAS P.G12C Addario Lung Cancer Medical Institute 58
Not applicableStudy completedNCT03981679What this trial is testingCirculating-free DNA Assessment as a Tool to Predict Colorectal Cancer in Subjects With a Positive Fecal Immunoassay.Who this might be right forColorectal Cancer Institut du Cancer de Montpellier - Val d'Aurelle 278
Early research (Phase 1)Looking for participantsNCT05366179What this trial is testingAutologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3TcWho this might be right forGlioblastoma Multiforme UNC Lineberger Comprehensive Cancer Center 36
Early research (Phase 1)Study completedNCT02561962What this trial is testingStudy in Subjects With Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Amgen 42
Not applicableLooking for participantsNCT06408402What this trial is testingImpact of Environmental Exposures on Tumor Risk in SDHx-mutation CarriersWho this might be right forSDH-Related Familial ParagangliomaSDHx-Related SyndromesSDH Gene Mutation+1 more Assistance Publique - Hôpitaux de Paris 1,300